SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Orchid Pharma informs about investor presentation

17 Jun 2021 Evaluate
In furtherance to the letter dated June 08, 2021 regarding Schedule of Analysts/ Institutional Investors meeting (Non-deal road show) scheduled for the month of June 2021, Orchid Pharma has informed that it enclosed the presentation to be made before the Institutional investors/ Analysts.

The above information is a part of company’s filings submitted to BSE.

Orchid Pharma Share Price

547.70 -22.80 (-4.00%)
20-Apr-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1226.10
Cipla 1228.55
Zydus Lifesciences 935.00
Lupin 2326.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×